ArticleClinical and translational science2016
The Role of Next-Generation Sequencing in Enabling Personalized Oncology Therapy.
Article in Clinical and translational science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Multifocal Oral Mucosal Melanoma with an Atypical Clinical Presentation.Dentistry journal · 2025Article
- Genomic and micro-environmental insights into drug resistance in colorectal cancer liver metastases.Discover oncology · 2025Article
- Potential barriers to implementation of next-generation sequencing in cancer management: a U.S. Physician-based survey.Future oncology (London, England) · 2025Article
- The Genomic Landscape of Colorectal Cancer in the Saudi Arabian Population Using a Comprehensive Genomic Panel.Diagnostics (Basel, Switzerland) · 2023Article
- Urban-Rural and Socioeconomic Differences in Patient Knowledge and Perceptions of Genomic Tumor Testing.JCO precision oncology · 2023Article
- Multiplexed Liquid Biopsy and Tumor Imaging Using Surface-Enhanced Raman Scattering.Biosensors · 2021Review
- Accessing Targeted Therapies: A Potential Roadblock to Implementing Precision Oncology?JCO oncology practice · 2021Article
- MicroRNA-Based Cancer Mortality Risk Scoring System and hTERT Expression in Early-Stage Oral Squamous Cell Carcinoma.Journal of oncology · 2021Article
- Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients.Scientific reports · 2020Article
- Replication Fork Remodeling and Therapy Escape in DNA Damage Response-Deficient Cancers.Frontiers in oncology · 2020Review
- Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection.Molecular diagnosis & therapy · 2019Article
- Rational "Error Elimination" Approach to Evaluating Molecular Barcoded Next-Generation Sequencing Data Identifies Low-Frequency Mutations in Hematologic Malignancies.The Journal of molecular diagnostics : JMD · 2019Article
- A Canadian guideline on the use of next-generation sequencing in oncology.Current oncology (Toronto, Ont.) · 2019Article
- Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology.Cancer biology & medicine · 2019Article
- Cancer biomarker discovery and translation: proteomics and beyond.Expert review of proteomics · 2019Article
- A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids.Communications biology · 2019Article
- Next-generation sequencing in precision oncology: Patient understanding and expectations.Cancer medicine · 2019Article
- Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations.JCO precision oncology · 2019Article
- Scalable Multiplexed Drug-Combination Screening Platforms Using 3D Microtumor Model for Precision Medicine.Small (Weinheim an der Bergstrasse, Germany) · 2018Article
- LACES and bootstraps: the hunt for prognostic and predictive markers for adjuvant therapy in NSCLC.Translational lung cancer research · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.